Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients
about
Chronic lymphocytic leukemia: a clinical review including Korean cohortsRichter transformation of CLL.Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cRichter's transformation to diffuse large B-cell lymphoma: a retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group.Phase II study of alemtuzumab-rituximab therapy in previously untreated patients with chronic lymphocytic leukemia: short- and long-term outcomes.Second cancers and Richter transformation are the leading causes of death in patients with trisomy 12 chronic lymphocytic leukemia.Single arm NCRI phase II study of CHOP in combination with Ofatumumab in induction and maintenance for patients with newly diagnosed Richter's syndrome.Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison to de novo Hodgkin lymphoma.High Viral Loads of Epstein-Barr Virus DNA in Peripheral Blood of Patients with Chronic Lymphocytic Leukemia Associated with Unfavorable Prognosis.Safety and activity of BTK inhibitor ibrutinib combined with ofatumumab in chronic lymphocytic leukemia: a phase 1b/2 study.Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes.Immunoglobulin gene translocations in chronic lymphocytic leukemia: A report of 35 patients and review of the literature.Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institutionRichter Transformation of Chronic Lymphocytic Leukemia: A Review of Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography and Molecular DiagnosticsHow we treat Richter syndrome.Risk factors for Richter syndrome in chronic lymphocytic leukemia.Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.The genomic landscape of chronic lymphocytic leukaemia: biological and clinical implications.An update for Richter syndrome - new directions and developments.Histologic transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma.Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.Herpes simplex infection simulating Richter transformation: a series of four cases and review of the literature.Effect of first-line treatment on second primary malignancies and Richter's transformation in patients with CLL.Richter Syndrome in Chronic Lymphocytic Leukemia.NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome.Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma.Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia.Histological transformation to diffuse large B-cell lymphoma in patients with Waldenström macroglobulinemia.Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell Transplant.Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease.Diffuse large B-cell lymphoma in patients with chronic lymphocytic leukemia: A single center experience.NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia.Second lung malignancy and Richter syndrome in chronic lymphocytic leukemia: case report and literature reviewConcomitant Presence of CD5-Positive Diffuse Large B-Cell Lymphoma and Monoclonal B Cells with the "CLL Immunophenotype" - Is It Richter's Transformation?A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor.Treatment of Richter's Syndrome.Approach to Richter transformation of chronic lymphocytic leukemia in the era of novel therapies.Management of patients with chronic lymphocytic leukemia at high risk of relapse on ibrutinib therapy.Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis.Characterizing patients with multiple chromosomal aberrations detected by FISH in chronic lymphocytic leukemia.
P2860
Q26752467-B7D09703-AD94-411C-8E03-47FE4BD21BE3Q30249283-252071D8-C5DC-4E00-B6CC-30808566F33EQ30408922-9279E7FC-33E5-45E9-8847-27DDE7C72F7FQ30841807-19321C6A-32EC-4EBC-B8BF-C899D547CDE0Q33414468-7F48676D-0CEA-44FD-8D96-4CACDE33E6B2Q33421376-0C510DCA-8347-4D9B-8F31-24296A9928F2Q35086905-829CB795-8293-408D-B90B-2E683B9AF43DQ35626311-8D3B2DCC-71C7-4B09-8ED5-E7C917A466C3Q35804493-7A0AB703-5F2C-4713-86C5-4AADCAA1377AQ35953518-DB6DE19A-66FC-44E5-8320-6B2EF6DE9999Q35985600-7D6A3F27-B7D5-442C-BF1D-7E666B599E90Q36824956-0A3E438B-B209-4BFC-9DC8-A6F57E4C57D5Q36825799-C0A707F2-AE51-48E4-9634-F391CA539DB1Q37632830-1B5D3AC7-BCDE-42AA-9863-75A90699823CQ37636962-E5B99BAB-B7FE-472A-AE34-82A260082903Q38248873-0F70264D-F493-4654-8DBC-42A941E40640Q38263924-44EE65A2-97B2-4C74-BC5D-3738F0CA50C4Q38286344-CE26AA32-5724-4990-BB60-5BA6F46AE944Q38691261-37656787-380C-4391-A2A4-CD129AC89413Q38896306-C45C8CA5-EE8F-464E-801A-FA6C3EF79B06Q38962267-B4B2C13F-85CA-47CA-8F7D-8EAB2A1796C5Q39025300-DA55116F-0412-4C92-8E70-488237555315Q39227230-6C4DAC39-C350-4217-95D7-F8DA1FFC48E1Q40037434-BC6A94BE-CF3B-46C2-9486-31038D91B56BQ40098409-9650D7ED-AB02-4A26-9E52-AA460C511BBCQ40291554-6DDB0BF6-7346-4852-8EE6-69B226A35EEEQ40397638-A8ABC553-E032-4EDD-AD7B-484EEF0B99BEQ40651796-ACB30086-7A7B-4869-94B3-0DB105B693E2Q40955026-2016780F-FF27-45D5-82FC-3D060A993F49Q41481956-8FABA3B9-5CA3-43F6-9FF2-5EB09F1E3C10Q41807963-CEB2BA08-6657-49BF-A76B-36B440C10972Q41819322-E4F923A7-F5A3-4591-9CEF-9007B45C00B5Q42229190-B02DC66F-B15D-40F6-99B4-FF8AC52D2517Q42250734-6EE2BEE1-C0DC-4F8B-8098-48B2D0D1D069Q48204203-6E411FA7-5CA7-4FE4-B0F2-75B226204D62Q49843910-EF2869AF-DC16-40DD-AF47-10D773AA79DAQ50074012-8F73D77B-EB84-47F9-9551-EEDEF3FCED42Q50110556-7C6EC08C-3018-4478-BF35-9569FEB91906Q50118872-36C14F34-1C1F-4DCB-8704-681A335DD0BFQ50524485-15DBE1A4-D721-4CB3-A8BB-601C16A6C5B5
P2860
Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Diffuse large B-cell lymphoma ...... dy of newly diagnosed patients
@ast
Diffuse large B-cell lymphoma ...... dy of newly diagnosed patients
@en
type
label
Diffuse large B-cell lymphoma ...... dy of newly diagnosed patients
@ast
Diffuse large B-cell lymphoma ...... dy of newly diagnosed patients
@en
prefLabel
Diffuse large B-cell lymphoma ...... dy of newly diagnosed patients
@ast
Diffuse large B-cell lymphoma ...... dy of newly diagnosed patients
@en
P2093
P2860
P921
P356
P1476
Diffuse large B-cell lymphoma ...... dy of newly diagnosed patients
@en
P2093
Clive S Zent
Curtis A Hanson
Jose F Leis
Kari G Rabe
Neil E Kay
Sameer A Parikh
Susan L Slager
Susan M Schwager
Tait D Shanafelt
Thomas M Habermann
P2860
P304
P356
10.1111/BJH.12458
P407
P577
2013-07-11T00:00:00Z